Literature DB >> 1597140

Exogenously administered testosterone maintains spermatogenesis quantitatively in adult rats actively immunized against gonadotropin-releasing hormone.

C A Awoniyi1, B R Zirkin, V Chandrashekar, W D Schlaff.   

Abstract

The administration of testosterone via Silastic capsules has been shown previously to maintain advanced spermatid number quantitatively in intact rats in which LH but not FSH was suppressed, but not in hypophysectomized rats, indicating that pituitary factors in addition to LH are required for the quantitative maintenance of spermatogenesis in the rat. The objective of the present study was to examine whether testosterone is capable of maintaining quantitatively normal spermatogenesis in rats in which both LH and FSH are suppressed. Intact adult male rats were actively immunized against GnRH by intradermal injection of GnRH conjugated to human serum globulin; control rats received intradermal injections of saline and adjuvant. Four weeks after the primary immunization, GnRH-immunized rats received the first booster injection and, at the same time, received testosterone-filled polydimethylsiloxane (PDS) implants of 4, 8, 12, or 24 cm or empty implants. Booster injections were repeated every 2 weeks for 8 weeks. At that time, rats were killed, and serum levels of LH, FSH, and testosterone, testicular advanced spermatid number, and seminiferous tubule fluid testosterone concentrations were determined. Four weeks after the initial administration of GnRH immunogen, i.e. before the first booster injection, serum levels of testosterone, LH, and FSH and the number of advanced spermatids per testis were not different from those in controls. Eight weeks after the first booster injection, serum LH and FSH and advanced spermatids were undetectable in all GnRH-immunized rats. The administration of testosterone-filled PDS implants of 4 and 8 cm to GnRH-immunized rats for 8 weeks resulted in the maintenance of 105 +/- 6 and 161 +/- 5 x 10(6) advanced spermatid/testis, respectively, significantly less than the control value (237 +/- 19 x 10(6)). In GnRH-immunized rats that received testosterone-filled PDS implants of 12 or 24 cm, the advanced spermatid numbers per testis (228 +/- 4 and 229 +/- 8 x 10(6), respectively) were not significantly different from those in controls. These results indicate that testosterone is capable of maintaining spermatogenesis quantitatively in the adult rats testis, in the absence of both radioimmunoassayable LH and FSH.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597140     DOI: 10.1210/endo.130.6.1597140

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Simultaneous quantification of steroids in rat intratesticular fluid by HPLC-isotope dilution tandem mass spectrometry.

Authors:  Alissa Renne; Lindi Luo; Jonathan Jarow; William W Wright; Terry R Brown; Haolin Chen; Barry R Zirkin; Marlin D Friesen
Journal:  J Androl       Date:  2011-10-20

2.  Hormonal control of inhibin B in men.

Authors:  V A Giagulli; D Carbone
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

3.  Leydig Cell and Spermatogenesis.

Authors:  Ren-Shan Ge; Xiaoheng Li; Yiyan Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception.

Authors:  Amanda Jones; Jiyun Chen; Dong Jin Hwang; Duane D Miller; James T Dalton
Journal:  Endocrinology       Date:  2008-09-04       Impact factor: 4.736

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.